Detalhe da pesquisa
1.
Treatment of HCC with claudin-1-specific antibodies suppresses carcinogenic signaling and reprograms the tumor microenvironment.
J Hepatol
; 78(2): 343-355, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36309131
2.
In vivo proof of concept of adoptive immunotherapy for hepatocellular carcinoma using allogeneic suicide gene-modified killer cells.
Mol Ther
; 22(3): 634-644, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24445938
3.
In vivo combination of human anti-envelope glycoprotein E2 and -Claudin-1 monoclonal antibodies for prevention of hepatitis C virus infection.
Antiviral Res
; 162: 136-141, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30599173
4.
Frequent compartmentalization of hepatitis C virus with leukocyte-related amino acids in the setting of liver transplantation.
J Infect Dis
; 198(11): 1656-66, 2008 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18925843
5.
Early evolution of hepatitis C virus (HCV) quasispecies after liver transplant for HCV-related disease.
J Infect Dis
; 196(4): 528-36, 2007 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17624837
6.
Early decrease in circulating dendritic cells number after liver transplantation could favor hepatitis C virus recurrence.
J Med Virol
; 78(8): 1070-5, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16789017